Liquidia (LQDA) Competitors $11.10 +0.51 (+4.82%) (As of 12/20/2024 05:31 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends LQDA vs. AXNX, NVCR, NVST, NARI, IRTC, LIVN, ENOV, WRBY, CNMD, and TNDMShould you be buying Liquidia stock or one of its competitors? The main competitors of Liquidia include Axonics (AXNX), NovoCure (NVCR), Envista (NVST), Inari Medical (NARI), iRhythm Technologies (IRTC), LivaNova (LIVN), Enovis (ENOV), Warby Parker (WRBY), CONMED (CNMD), and Tandem Diabetes Care (TNDM). These companies are all part of the "medical equipment" industry. Liquidia vs. Axonics NovoCure Envista Inari Medical iRhythm Technologies LivaNova Enovis Warby Parker CONMED Tandem Diabetes Care Liquidia (NASDAQ:LQDA) and Axonics (NASDAQ:AXNX) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their media sentiment, risk, earnings, profitability, institutional ownership, dividends, analyst recommendations, valuation and community ranking. Which has stronger valuation and earnings, LQDA or AXNX? Axonics has higher revenue and earnings than Liquidia. Axonics is trading at a lower price-to-earnings ratio than Liquidia, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioLiquidia$15.61M60.18-$78.50M-$1.63-6.81Axonics$366.38M9.90-$6.09M-$0.12-591.45 Does the MarketBeat Community favor LQDA or AXNX? Liquidia received 27 more outperform votes than Axonics when rated by MarketBeat users. Likewise, 68.14% of users gave Liquidia an outperform vote while only 66.41% of users gave Axonics an outperform vote. CompanyUnderperformOutperformLiquidiaOutperform Votes20168.14% Underperform Votes9431.86% AxonicsOutperform Votes17466.41% Underperform Votes8833.59% Is LQDA or AXNX more profitable? Axonics has a net margin of -1.31% compared to Liquidia's net margin of -765.38%. Axonics' return on equity of 0.36% beat Liquidia's return on equity.Company Net Margins Return on Equity Return on Assets Liquidia-765.38% -163.21% -67.14% Axonics -1.31%0.36%0.31% Which has more risk & volatility, LQDA or AXNX? Liquidia has a beta of 0.22, indicating that its share price is 78% less volatile than the S&P 500. Comparatively, Axonics has a beta of 0.82, indicating that its share price is 18% less volatile than the S&P 500. Do institutionals and insiders hold more shares of LQDA or AXNX? 64.5% of Liquidia shares are held by institutional investors. Comparatively, 99.5% of Axonics shares are held by institutional investors. 30.1% of Liquidia shares are held by insiders. Comparatively, 1.9% of Axonics shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. Does the media refer more to LQDA or AXNX? In the previous week, Liquidia had 6 more articles in the media than Axonics. MarketBeat recorded 6 mentions for Liquidia and 0 mentions for Axonics. Liquidia's average media sentiment score of 0.74 beat Axonics' score of 0.00 indicating that Liquidia is being referred to more favorably in the media. Company Overall Sentiment Liquidia Positive Axonics Neutral Do analysts recommend LQDA or AXNX? Liquidia presently has a consensus target price of $25.38, suggesting a potential upside of 128.60%. Axonics has a consensus target price of $71.00, suggesting a potential upside of 0.03%. Given Liquidia's stronger consensus rating and higher probable upside, analysts clearly believe Liquidia is more favorable than Axonics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Liquidia 0 Sell rating(s) 1 Hold rating(s) 6 Buy rating(s) 2 Strong Buy rating(s) 3.11Axonics 0 Sell rating(s) 8 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 SummaryLiquidia beats Axonics on 11 of the 19 factors compared between the two stocks. Ad True Market InsidersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team of crypto experts has identified it as the most promising crypto of 2024. You can see all of the details surrounding the #1 Crypto of 2024>3-Cent Amazon Coin< Get Liquidia News Delivered to You Automatically Sign up to receive the latest news and ratings for LQDA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart LQDA vs. The Competition Export to ExcelMetricLiquidiaPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$896.31M$6.57B$5.12B$9.07BDividend YieldN/A2.98%4.91%4.22%P/E Ratio-6.8110.5991.3417.19Price / Sales60.18195.381,116.59116.80Price / CashN/A57.1642.6437.86Price / Book15.215.104.794.78Net Income-$78.50M$151.51M$120.07M$225.60M7 Day Performance1.65%-2.15%-1.89%-1.24%1 Month Performance9.36%-3.14%11.45%3.36%1 Year Performance-1.51%11.50%30.61%16.58% Liquidia Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)LQDALiquidia3.4225 of 5 stars$11.10+4.8%$25.38+128.6%+3.7%$896.31M$15.61M-6.8150Analyst ForecastNews CoveragePositive NewsHigh Trading VolumeAXNXAxonics1.4204 of 5 stars$70.98+0.8%$71.00+0.0%+20.9%$3.63B$366.38M-591.45610High Trading VolumeNVCRNovoCure2.4915 of 5 stars$32.84-1.7%$32.67-0.5%+138.4%$3.55B$577.74M-23.861,453NVSTEnvista3.9074 of 5 stars$19.52+0.3%$20.65+5.8%-21.1%$3.36B$2.50B-2.5112,800Positive NewsNARIInari Medical3.3112 of 5 stars$55.46-0.2%$58.89+6.2%-11.9%$3.25B$574.50M-41.181,300Analyst ForecastInsider TradeIRTCiRhythm Technologies3.0956 of 5 stars$89.29+3.3%$107.82+20.8%-14.3%$2.79B$492.68M-17.782,000Analyst ForecastLIVNLivaNova3.626 of 5 stars$50.11-2.7%$69.17+38.0%-4.4%$2.72B$1.24B122.622,900Analyst UpgradePositive NewsENOVEnovis2.9783 of 5 stars$46.44+0.7%$67.00+44.3%-21.5%$2.59B$2.00B-21.396,550Positive NewsWRBYWarby Parker1.5771 of 5 stars$24.31+2.9%$20.73-14.7%+99.1%$2.47B$669.77M-87.523,491Insider TradeCNMDCONMED4.6139 of 5 stars$71.56-1.4%$79.80+11.5%-36.7%$2.21B$1.29B17.234,000Positive NewsTNDMTandem Diabetes Care4.6384 of 5 stars$33.41+2.3%$53.81+61.1%+30.3%$2.19B$747.72M-16.922,400Positive News Related Companies and Tools Related Companies Axonics Competitors NovoCure Competitors Envista Competitors Inari Medical Competitors iRhythm Technologies Competitors LivaNova Competitors Enovis Competitors Warby Parker Competitors CONMED Competitors Tandem Diabetes Care Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:LQDA) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredVideo: Blindfolded Man Gets Into a Cybertruck… What Happens Next Will Shock You“Hi, I’m Jeff Brown… Even though I can’t see a thing… I’m about to get in this Cybertruck and drive up t...Brownstone Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Liquidia Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Liquidia With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free LQDA Stock Alerts